Endeavour of govt is to provide affordable quality healthcare for all: Gowda

New Delhi: The government Thursday said it endeavours to provide affordable quality healthcare for all while also working to boost the domestic pharmaceutical sector through ‘Make in India’. As part of its efforts to give an impetus to the sector, Union Minister for Chemicals and Fertilisers D V Sadananda Gowda will meet leaders of pharmaceutical and medical devices industry to discuss policy and challenges facing the industry, during the international conference being organised in Bengaluru in February.

“The endeavour of the government is to provide affordable quality healthcare for all and boost indigenous pharma sector through ‘Make in India’,” Gowda said while addressing media during a curtain raiser for ‘India Pharma 2019 & India Medical Device 2019’ here.

The minister further said to boost the sector, the Cabinet has already given approval for 100 per cent FDI under automatic route for manufacturing of medical devices.

The Department of Pharmaceuticals, under the Ministry of Chemicals and Fertilizers, along with the Federation of Indian Chambers of Commerce and Industry, is organising the 4th International Conference on Pharmaceutical & Medical Devices sector on February 18 and 19 in Bengaluru.

Seeking to address concerns of the industry over various issues, including price control, the minister said the event would provide an opportunity to discuss government policy and challenges facing the industry.

“The government is striving to make the processes in the sector as transparent and easy as possible,” he added.

The flagship event would bring key stakeholders of the pharma and medical devices sectors under one roof, Gowda said.

The theme for India Pharma 2019 is ‘Enabling Quality Affordable Healthcare’ and that of India Medical Device 2019 is ‘Med-Tech India: Gearing up for Ayushman Bharat’.
NewsletterA A

  • Related Posts

    Four new drugs for rare diseases on anvil; five medications for 7 ailments in market: VK Paul

    New Delhi: Four new drugs for rare diseases are in the pipeline expected to be launched soon while five medications for seven illnesses have already been introduced in the market…

    Telangana HM orders action against misleading pharma ads, sale of substandard drugs

    Hyderabad: In a stern message to the pharmaceutical industry, Telangana Health Minister Damodar Rajanarsimha has ordered the Drug Control Authority (DCA) to take stringent action against companies and individuals involved…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Four new drugs for rare diseases on anvil; five medications for 7 ailments in market: VK Paul

    Four new drugs for rare diseases on anvil; five medications for 7 ailments in market: VK Paul

    Telangana HM orders action against misleading pharma ads, sale of substandard drugs

    Telangana HM orders action against misleading pharma ads, sale of substandard drugs

    Aurobindo Pharma clarifies, reports of Zentiva buyout ‘premature’, no binding agreement yet

    Aurobindo Pharma clarifies, reports of Zentiva buyout ‘premature’, no binding agreement yet

    AIIMS study finds catheter infections in hospital widespread across India

    AIIMS study finds catheter infections in hospital widespread across India